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INTRODUCTION
Integrins are a major family of transmembrane cell-surface
receptors used primarily in cell-matrix interactions important
for many diverse biological processes, such as embryonic
development, wound healing, tumor cell metastasis and tissue
differentiation (Adams and Watt, 1993). Integrins are a /b
heterodimers, and the specificity of integrins for particular
extracellular ligands depends upon which a and b subunits
comprise the integrin heterodimer (Hynes, 1992). Integrins
generally concentrate in multi-protein, cell-matrix adhesion
complexes, where integrin extracellular domains directly
interact with matrix proteins such as fibronectin (FN), laminin
and collagen, and their intracellular domains interact with the
cell’s cytoskeletal and signal transduction apparatus (Clark and
Brugge, 1995; Yamada and Miyamoto, 1995). 
Integrins containing b 1, b 3, and b 5 subunits interact with the
microfilament system and localize to adhesion complexes
known as focal adhesions (Sastry and Horwitz, 1993). In
contrast, the a 6b 4 integrin is thought to interact primarily with
the keratin intermediate filament system because of its
localization in type I hemidesmosomes in stratified epithelial
cells (Stepp et al., 1990), although it can also interact with the
actin cytoskeleton in migrating cells (Rabinovitz and Mercurio,
1997; Shaw et al., 1997). Type I hemidesmosomes are
specialized cell-substrate junctions that mediate the adhesion
of stratified epithelial cells to the underlying laminin 5-rich
basement membrane. Ultrastructurally, type I
hemidesmosomes are described as regions of the plasma
membrane in close contact with the laminin 5-containing
basement membrane, characterized by distinct electron-dense
cytoplasmic plaques where keratin intermediate filaments are
anchored (Green and Jones, 1996; Jones et al., 1994). In
addition to a 6b 4, several other components of type I
hemidesmosomes have been identified, including the
transmembrane protein BP180, and several intracellular plaque
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The a 6b 4 laminin binding integrin functions in the
assembly of type I hemidesmosomes, which are specialized
cell-matrix adhesion sites found in stratified epithelial cells.
Although endothelial cells do not express all the
components of type I hemidesmosomes, endothelial cells
can express the a 6b 4 integrin. Because endothelial cells lose
expression of a 6b 4 in culture, we expressed recombinant
a 6b 4 in the dermal microvascular endothelial cell line,
HMEC-1, to test whether endothelial cells can assemble
adhesion structures containing a 6b 4. Using
immunofluorescence microscopy, we found that
recombinant a 6b 4 concentrates specifically in a novel
fibrillar structure on the basal surface of endothelial cells
in the absence of an exogenous laminin substrate. This
localization is regulated by an intracellular mechanism,
because the b 4 cytoplasmic domain is sufficient to direct a
reporter domain (IL-2R) to the fibrillar structures
independently of recombinant a 6b 4. In addition, this IL-
2R-b 4 chimera is sufficient to recruit the intermediate
filament-associated protein HD1/plectin to these fibrillar
structures and this also occurs in the absence of
recombinant a 6b 4. The fibrillar localization pattern, as well
as the recruitment of HD1/plectin, requires the first and
second fibronectin type III repeats and the connecting
segment of the b 4 tail. In addition, when endothelial cells
are provided a laminin 5-rich matrix, recombinant a 6b 4
redistributes from the fibrillar structure to type I
hemidesmosome-like structures. The b 4 cytoplasmic
domain can also direct a reporter domain to these type I
hemidesmosome-like structures; however, this process is
dependent upon the expression of recombinant a 6b 4.
Biochemical analysis indicates that both the fibrillar and
the type I hemidesmosome-like structures are associated
with the vimentin intermediate filament cytoskeleton.
Thus, the results illustrate that endothelial cells have the
essential components necessary to assemble at least two
distinct a 6b 4-containing and vimentin-associated
structures on their basal surface and that the b 4
cytoplasmic tail and the availability of specific a 6b 4 ligands
regulate receptor localization to these structures. 
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proteins, including IFAP300, HD1, plectin and BP230.
Although the role of these proteins in hemidesmosome
formation is not yet known, IFAP300, HD1, plectin and BP230
are related proteins (Green and Jones, 1996), and are all likely
to have the ability to bind intermediate filaments (Skalli et al.,
1994; Foisner et al., 1988; Guo et al., 1995). Since current
evidence indicates that HD1 and plectin are the same protein,
we will refer to them as HD1/plectin (McLean et al., 1996;
Smith et al., 1996; Gache et al., 1996). 
Although type I hemidesmosomes are primarily limited to
basal stratified epithelial cells, HD1/plectin and a 6b 4 are found
in cell types such as endothelial cells, that do not form
ultrastructurally defined type I hemidesmosomes. In these
cells, it has been suggested that HD1/plectin and a 6b 4 are
assembled into less organized multiprotein complexes, for
which the term type II hemidesmosomes has been given to
distinguish them from the ‘classical’ type I hemidesmosome of
basal epidermal cells (Uematsu et al., 1994). Type II
hemidesmosomes are defined as structures having a 6b 4 and
HD1/plectin, but lacking BP180 and BP230, as well as the
electron-dense intracellular plaques (Hieda et al., 1992). In the
mammary gland epithelial cell line, BMGE-H, a 6b 4 and
HD1/plectin have been observed in structures which flank
vinculin-containing focal adhesions (Uematsu et al., 1994).
These structures have also been referred to as type II
hemidesmosomes. The extracellular matrix protein associated
with these structures remains unidentified. Interestingly,
similar structures can be identified in fibroblastic cells
expressing recombinant a 6b 4 (Sanchez-Aparicio et al., 1997;
Niessen et al., 1997a).
The function of a 6 b 4 in endothelial cells is currently
unknown. However, since endothelial cells express a 6 b 4 and
HD1/plectin in situ (Hieda et al., 1992), a 6 b 4 may function in
endothelial cells by connecting the vimentin intermediate
filament cytoskeleton to the plasma membrane at sites of cell-
matrix adhesion. Because endothelial cells lose expression of
a 6 b 4 in culture (Hieda et al., 1992), we expressed recombinant
a 6 b 4 in endothelial cells and asked whether recombinant a 6 b 4
can localize to adhesion structures and whether these
structures are distinct from those observed in epithelial and
fibroblastic cells in culture. We found that recombinant a 6 b 4
concentrates specifically in a novel fibrillar adhesion-like
structure in the absence of exogenous ligand, and that receptor
localization to this structure occurs by an intracellular
mechanism dependent on the b 4 cytoplasmic domain.
Additionally, we demonstrate that the b 4 cytoplasmic domain
is sufficient to recruit HD1/plectin to these fibrillar structures
and that these structures are associated with vimentin
intermediate filaments. We also show that laminin 5 causes the
redistribution of a 6 b 4 from the fibrillar structures to type I
hemidesmosome-like structures, which are also associated
with vimentin intermediate filaments. Thus, the localization of
a 6 b 4 in distinct vimentin-associated structures in endothelial
cells can be regulated by the availability of specific ligands for
a 6 b 4.
MATERIALS AND METHODS
Construction of chimeric receptors
To generate a plasmid encoding a chimeric receptor containing the
interleukin-2 receptor extracellular and transmembrane reporter
domains connected to the b 4 subunit intracellular domain (IL-2R-b 4
chimera), the oligonucleotides 5¢ -AGCTTGCCGTCTACGCTGGGC-
3¢ and 5¢ -TCGAGCCCAGCGTAGACGGCA-3¢ , encoding an AccI,
site were hybridized and then inserted at the HindIII/XhoI sites of the
previously described plasmid encoding the extracellular and
transmembrane domains of the IL-2 receptor (LaFlamme et al., 1992).
The cDNA, b 4-1, a kind gift of Dr Shintaro Suzuki (University of
Southern California School of Medicine) was subcloned into the EcoRI
site of pUC19, generating the plasmid pUC19-b 4-1. The AccI/XbaI
fragment of pUC19-b 4-1, encoding amino acids 854-1752 (Suzuki and
Naitoh, 1990), was then inserted into the newly generated AccI site and
existing XbaI site, generating the plasmid CMV-IL2R-b 4. To construct
b 4-D 1315-1752, containing a truncation after the second FN Type III
repeat, a stop codon was inserted at amino acid 1315 by hybridizing
the following oligonucleotides: 5¢ -CGCGCAACGGGGCCGGC-
TGGGGGCCTGAGCGGGAGGCCATCATCTGATAGT-3¢ and 5¢ -
CTAGACTATCAGATGATGGCCTCCCGCTCAGGCCCCCAGCC-
GGCCCCGTTG-3¢ and ligating them into the plasmid CMV-IL-2R-b 4
in place of the BssHII/XbaI fragment of the full-length b 4 tail. To
construct b 4-D 1488-1752, containing a truncation after the connecting
segment (CS), a stop codon was inserted at amino acid 1488 by
hybridizing the oligonucleotides 5¢ -GGCCGCTGTGATAGCCCG-
TGT-3¢ and 5¢ -CTAGACACGGGCTATCACAGC-3¢ and then ligating
them into plasmid CMV-IL2R-b 4 in place of the Notl/XbaI fragment
of the full-length b 4 tail. b 4-D 1315-1456, lacking the CS, was
generated using the polymerase chain reaction (PCR). Initially, two
PCR products were generated using the plasmid CMV-IL-2R-b 4 as a
template and the following primers: Reaction (1) NH2-terminal primer
1, 5¢ -TGAGATCACAGCCTA-3¢ , which hybridized upstream of the
BssHII site, and COOH-terminal primer 2, 5¢ -CGGGTGGGC-
GTGTCGGGCACGATGATGGCCTCCCGCTCAG-3¢ . Reaction (2)
NH2-terminal primer 3, 5¢ -CTGAGCGGGAGGCCATCATCGT-
GCCCGACACGCCCACCCG-3¢ and COOH-terminal primer 4, 5¢ -
GTTGGGCAGGAGGTC-3¢ , which hybridized downstream of the
NotI site. The products of these reactions were combined and used as
a template for PCR using the primers 1 and 4 listed above. The product
of this reaction was digested with BssHII and NotI and then ligated
into CMV-IL-2R-b 4 in place of the BssHII/NotI fragment of the full-
length b 4 tail. The b 4-1315-1456 mutant, encoding only the CS, and
b 4-1218-1456 mutant encoding the second FN type III repeat and the
CS, were also generated using PCR. The plasmid CMV-IL-2R-b 4 and
the primer 5¢ -GAGTCTCTCGAGTCAACCAGCAGTCAGGCG-3¢ ,
were used for both reactions and the primer 5¢ -AGGGACA-
AGCTTACCCTGGCCACCCAGCCC-3¢ was used to generate b 4-
1315-1456 and the primer 5¢ -AGGGACAAGCTTGTGCCCAG-
CGAGCCAGGG-3¢ was used to generate b 4 1218-1456. Each product
was then digested with XhoI and HindIII and was ligated to the CMV-
IL-2R plasmid as a HindIII/XhoI fragment. The construction of each
mutant was confirmed by DNA sequence analysis (Sambrook et al.,
1989). The construction of cDNA clones encoding the full-length a 6A
and b 4A subunits were described previously (Clarke et al., 1995; Shaw
et al., 1993). 
Cells
The human dermal microvascular endothelial cell line, HMEC-1, was
a generous gift from Drs Thomas Lawley (Emory University School
of Medicine) and Edwin Ades (Centers for Disease Control) (Ades et
al., 1992). Early passage primary human dermal microvascular
endothelial cells were purchased from VEC Technologies (Rensselaer,
NY) and were cultured as recommended by the provider. Normal
human foreskin fibroblasts and the adult human skin epithelial cell
line, HaCat, were cultured as previously described (LaFlamme et al.,
1992; Boukamp et al., 1988). Rat bladder carcinoma 804G cells
(Izumi et al., 1981) were a kind gift from Dr Ryoichi Oyasu
(Northwestern University).
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Immunological reagents
Several commercial antibodies were used: mouse mAb clone VIN-11-
5 against vinculin and mouse mAb clone VIM 13.2 against vimentin
from Sigma Chemical Co. (St Louis, MO), mouse mAb clone VIM
3B4 against vimentin from Boehringer-Mannheim (Indianapolis, IN),
mouse mAb 3E1 against the b 4 subunit from Gibco-BRL
(Gaithersburg, MD), rat mAb GoH3 against the a 6 subunit from
Pharmingen (San Diego, CA), fluorescein (FITC)-conjugated, as well
as unconjugated, mouse mAb K20 against the b 1 subunit from
Immuntech (Westbrook, ME), mouse mAbs P1B5 and P1E6 against
the human a 3 and a 2 subunits, respectively, from Becton Dickinson
(Bedford, MA), FITC-conjugated mouse mAb against the human IL-
2 receptor from Accurate Chemical and Scientific Corporation
(Westbury, NY), mouse mAb 4E10 specific for the laminin b 1 chain
from Gibco BRL, and mouse mAb P3E4 against epiligrin from
Chemicon (Temecula, CA). Mouse mAbs C2-9 and B4-6, specific for
laminin chains a 3 and g 2 respectively, were a kind gift from Dr
William G. Carter (Carter et al., 1994). Rabbit polyclonal antiserum
to a C-terminal peptide of integrin b 4 was a kind gift from Dr Filippo
G. Giancotti (Giancotti et al., 1992). Mouse mAb-121 to HD1/plectin
was a kind gift from Dr Katsushi Owaribe (Nagoya University,
Nagoya, Japan) (Hieda et al., 1992). Rhodamine-conjugated goat anti-
mouse IgG was purchased from Boehringer-Mannheim (Indianapolis,
IN). Texas Red-conjugated donkey anti-rat IgG and FITC-conjugated
donkey anti-mouse IgG were purchased from Jackson
Immunoresearch Labs (West Grove, PA). 
Transfections, immunofluorescence and flow cytometry
Cells were transiently transfected using electroporation as previously
described (LaFlamme et al., 1992). Transfected cells were plated onto
glass coverslips in serum-containing medium or onto coverslips
coated with a laminin 5-rich matrix, purified as previously described
(Langhofer et al., 1993), or with purified laminin 1 (Becton
Dickinson) in serum-free medium for 2 hours, and then in medium
containing 10% fetal bovine serum overnight. Cells were fixed and
immunostained as previously described (LaFlamme et al., 1992). In
some cases, cells were extracted for 3 minutes at room temperature
with a ‘cytoskeletal’ extraction buffer containing 1% Tween-40, 0.5%
sodium deoxycholate, 10 mM NaCl, 2 mM MgCl2, 1 mM PMSF and
20 mM Tris-HCl, pH 7.4, prior to fixation. For dual-staining with two
mouse mAbs, the cells were first incubated with the unconjugated
mAb followed by rhodamine-conjugated goat anti-mouse IgG. To
block sites that may bind mouse IgG, coverslips were blocked for 30
minutes in 100 m g/ml normal mouse IgG (Cappel, Durham NC),
washed briefly and then incubated with the second mAb, which was
FITC-conjugated. For dual staining with the rat GoH3 mAb and
mouse mAb VIM 3B4, a Texas Red-conjugated anti-rat antibody pre-
absorbed with mouse IgG and a FITC-conjugated anti-mouse
antibody pre-absorbed with rat IgG (Jackson Immunoresearch Labs)
were used. The samples were analyzed using a 100· oil immersion
lens on an Olympus Model BX60 microscope equipped with
epifluorescence. Confocal microscope images were collected using a
Noran-Oz confocal laser scanning imaging system on a Nikon
Diaphot microscope using a 100 · oil immersion lens. Two
dimensional views of the z-series volume along the x-z and y-z planes
were produced using the reslice tool in the InterVision 3D software
(Noran Instruments, Madison, WI). Expression levels of the chimeric
receptors and the levels of endogenous expression of a 6b 4 and b 1
integrin subunits on HMEC-1 and HaCat cells were analyzed by flow
cytometry using a Becton Dickinson FACScan flow cytometer as
previously described (LaFlamme et al., 1994).
Cell fractionation and western blotting
An equal number of HMEC-1 cells transiently transfected with
recombinant human a 6A and b 4A subunits were plated in serum
containing medium onto two 100 mm dishes previously coated with
a laminin 5-rich matrix. After 36 hours, the cells were washed several
times in PBS. To generate a whole cell lysate, cells from one plate
were solubilized directly in 500 m l SDS-PAGE sample buffer (40 mM
NaPO4, 2% SDS, 10 mM EDTA) at 95°C, the DNA present was
sheared by passage through a 25-gauge needle, and the lysate was
clarified by centrifugation. Cells from the second plate were extracted
for 5 minutes in 500 m l of Tween-40/deoxycholate extraction buffer
described above, with the addition of 100 m M calpain inhibitor
(Boehringer-Mannheim). The soluble fraction was collected and
clarified by centrifugation. After several washes in PBS, the fraction
resistant to extraction (insoluble fraction) was solubilized with 350 m l
SDS-PAGE sample buffer at 95°C as described above. The protein
concentration in each fraction was determined using the Micro-BCA
protein assay from Pierce (Rockford, IL). 10 m g of protein from each
sample were resolved by 7.5% SDS-PAGE and then analyzed by
western blot with the anti- b 4 integrin polyclonal antibody. The filter
was then stripped for 1 hour at 70°C in 2% SDS, 100 mM b -
mercaptoethanol, and 62.5 mM Tris-HCl, pH 6.7, and reprobed with
the anti-vimentin mAb clone VIM 13.2. The stripping procedure was
repeated and the filter was probed a third time with the anti-vinculin
mAb clone VIN-11-5.
RESULTS
Recombinant a 6b 4 concentrates in fibrillar adhesion-
like structures in HMEC-1 cells
Expression of the a 6 b 4 integrin has been observed in a variety
of endothelial cells in situ including dermal microvascular
endothelial cells (Enenstein and Kramer, 1994; Hieda et al.,
1992; Kennel et al., 1992; Koukoulis et al., 1991). However,
when endothelial cells are placed in culture they lose
expression of a 6 b 4 (Hieda et al., 1992). Consistent with this
finding, primary dermal microvascular endothelial cells and
the human dermal microvascular endothelial cell line,
HMEC-1, express a 6 b 4 at low levels (Xu et al., 1994), which
are not detected in any distinct subcellular localization
pattern (data not shown). In order to evaluate whether the
inability to detect a 6 b 4 in adhesion structures in endothelial
cells is due to its low expression level, or to the absence of
other components required to assemble a 6 b 4 into distinct
adhesive structures, we expressed the recombinant human
a 6A and b 4A subunits in HMEC-1 cells and examined their
localization pattern using immunofluorescence microscopy.
In transiently transfected HMEC-1 cells, we observed
recombinant a 6 b 4 localized in novel fibrillar structures on the
basal cell surface (Fig. 1). The same fibrillar localization
pattern was observed for recombinant a 6 b 4 when expressed
in early passage primary dermal microvascular endothelial
cells (data not shown). This a 6 b 4-containing structure
appears to be distinct from the previously described type II
hemidesmosomes in epithelial cells and type II-like
hemidesmosomes in fibroblasts (Uematsu et al., 1994;
Niessen et al., 1997a). The majority of recombinant a 6 b 4
concentrates in fibrillar structures where vinculin is not
detected (data not shown). In the previously described
structures, a 6 b 4 was observed to flank vinculin-containing
focal adhesions. 
The b 4 intracellular domain is sufficient to target a
reporter to a 6b 4-containing fibrillar structures
We next tested whether the b 4 intracellular domain was
sufficient to direct the localization of a reporter to the fibrillar
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structures in endothelial cells. To do so, we constructed a
chimeric receptor containing an extracellular reporter domain
consisting of the IL-2 receptor extracellular and
transmembrane domain connected to the wild-type b 4 subunit
intracellular domain (IL-2R- b 4 chimera, see Fig. 2). When the
chimeric receptor was cotransfected with the recombinant a 6b 4
receptor into HMEC-1 cells, the chimeric receptor colocalized
with the recombinant a 6b 4 receptor in fibrillar structures on the
cell surface (Fig. 3). These results indicate that the b 4
cytoplasmic domain connected to an extracellular reporter can
interact with cytoplasmic components localized at these
fibrillar structures. The confocal images shown in Fig. 3
represent the optical plane corresponding to the basal cell
surface, suggesting that the fibrillar structures are concentrated
on the basal surface of the cell and therefore may function in
adhesion. 
An intracellular mechanism regulates receptor
localization at these fibrillar structures
Since a 6b 4 is a receptor for the laminin isoforms 1, 2, 4 and 5
(Spinardi et al., 1995; Lee et al., 1992), we tested whether
laminin colocalized with a 6b 4 at these fibrillar structures.
However, we could not detect laminin containing the b 1, b 2, a 3
or g 2 chains at these sites by immunofluorescence microscopy
(data not shown). This result suggests that a 6b 4 may be
targeted to these structures by an intracellular mechanism
rather than an extracellular receptor-ligand interaction. To
examine whether the localization of the b 4 chimera was
dependent upon the presence of the recombinant a 6b 4 receptor,
we transfected endothelial cells with only the wild-type IL-2R-
b 4 chimera and analyzed its distribution on the cell surface. We
found that it localized to the same fibrillar structures in the
S. M. Homan, A. M. Mercurio and S. E. LaFlamme
Fig. 1. Recombinant a 6 b 4 concentrates in fibrillar structures on the
surface of HMEC-1 cells. HMEC-1 cells were transiently transfected
with the a 6A and b 4A integrin subunits and seeded on glass
coverslips for 14-18 hours in serum-containing medium. The cells
were fixed and stained with mAb 3E1 specific for the b 4 subunit. The
samples were then analyzed on an Olympus Model BX60
microscope equipped with epifluorescence. Bar, 10 m m.
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Fig. 2. Schematic representation of chimeric receptors containing the
wild-type b 4 intracellular domain and various b 4 intracellular domain
deletion mutants. Chimeric receptors were constructed containing the
IL-2 receptor (IL2-R) extracellular and transmembrane (TM)
domains connected to either the wild-type or mutant b 4 cytoplasmic
tails. The four fibronectin type III repeats are numbered and
represented by the black boxes, and the tyrosine activation motif
(TAM)-containing connecting segment (CS) is represented by the
shaded region. Also shown are the control receptor containing only
the extracellular and transmembrane reporter domains, and the
chimeric receptor containing the b 1 intracellular domain.
Fig. 3. The b 4 intracellular domain is sufficient to direct a reporter domain to fibrillar structures on the basal surface of endothelial cells where
the recombinant a 6b 4 integrin concentrates. HMEC-1 cells were cotransfected with recombinant a 6 b 4 and the IL-2R- b 4 chimeric receptor and
seeded on glass coverslips in serum-containing medium as described in Fig. 1. The cells were fixed and dual-stained with antibodies specific for
the IL-2 receptor (A) or the a 6 b 4 integrin, mAb 3E1 (B). The overlayed image of A and B is shown in (C), illustrating the colocalization
(yellow) between the chimera and recombinant a 6 b 4. The images shown are optical sections collected from a confocal z-series scan
corresponding to the basal surface of the cell.
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absence of recombinant a 6b 4 (Fig. 4A) as it did in the presence
of recombinant a 6b 4 (Fig. 3). Therefore, it is possible that this
structure is assembled independently of a 6b 4-ligand
interactions. In addition, confocal microscopic analysis of
vertical sections indicated the staining was concentrated
specifically at the basal cell surface (Fig. 4A), whereas a
control chimera lacking an intracellular domain stained
diffusely on the cell surface (Fig. 4B). As an additional control,
we tested the ability of the b 4 chimera to target previously
characterized a 6b 4-containing type I hemidesmosomes in
culture (Hormia et al., 1995; Langhofer et al., 1993). We were
able to detect the b 4 chimera along with endogenous a 6b 4 at
hemidesmosomes in HaCat cells plated on a laminin 5-rich
matrix as indicated by the well-characterized hemidesmosomal
‘Swiss-cheese’-like staining pattern localized specifically on
the basal surface of the cell (Fig. 4C). These results indicate
that in the absence of recombinant a 6b 4, the b 4 intracellular
domain is sufficient to direct the chimeric receptor to distinct
fibrillar structures on the basal surface of endothelial cells. This
suggests that the b 4 intracellular domain interacts with cellular
protein(s) concentrated at these structures, which direct its
localization. 
The first pair of FN type III repeats and the
connecting segment are required for the localization
to fibrillar adhesion-like structures
The b 4 cytoplasmic domain contains conserved amino acid
motifs found to mediate protein-protein interactions in other
proteins (Campbell and Spitzfaden, 1994). These motifs
include two pairs of FN type III structural repeats separated by
a connecting segment (CS), which contains a tyrosine-
activation motif that has been shown to function in signal
transduction in other receptors (Timson-Gauen et al., 1996). It
has previously been shown that a region of the b 4 intracellular
domain contained within the first pair of FN type III repeats
and the CS is involved in regulating the localization of a 6b 4 to
type I hemidesmosomes in rat bladder carcinoma 804G cells
and type II hemidesmosome-like structures in fibroblastic cells
(Niessen et al., 1997a; Spinardi et al., 1993). To determine
whether the same or distinct regions of the b 4 cytoplasmic
domain are important for mediating the interactions directing
the chimera to the fibrillar structures in endothelial cells, we
constructed chimeric receptors containing various deletions in
the b 4 intracellular domain, focusing on the region of the b 4
tail containing the FN type III repeats and the CS (Fig. 2).
Similar levels of cell surface expression were observed for each
of these chimeric receptors by flow cytometry (data not
shown). The localization of each mutant was analyzed on
transiently transfected HMEC-1 cells by immunofluorescence
microscopy and the results from three independent experiments
were compared (Table 1). When we analyzed the cell surface
distribution of the chimeric receptors, we found that the second
pair of FN type III repeats is not required for the fibrillar
localization, since the chimeric receptor, b 4-D 1488-1752,
containing the b 4 cytoplasmic domain truncated after the CS,
showed the same fibrillar localization pattern as the wild-type
IL-2R- b 4 chimera (Fig. 5A,B). However, the CS is required for
the fibrillar localization pattern, since the chimeric receptors
b 4-D 1315-1752 and b 4-D 1315-1456, which lack the CS,
stained diffusely on the cell membrane (Fig. 5C,D). Although
the CS is required for the fibrillar localization, the CS is not
sufficient to direct the receptor to the fibrillar structures, since
the chimeric receptor b 4-1315-1456, containing only the CS,
was diffusely distributed on the cell surface (Fig. 5E). The
Fig. 4. The b 4 intracellular domain is sufficient to direct a reporter
domain to fibrillar structures in the absence of recombinant a 6 b 4.
HMEC-1 cells transiently expressing either the wild-type b 4 chimeric
receptor (A) or the control receptor (B) were seeded on glass
coverslips in serum-containing medium as previously described. As a
positive control for the ability of the b 4 chimera to target to type I
hemidesmosomes, a human keratinocyte cell line (HaCat) transiently
expressing the wild-type b 4 chimera was seeded on a laminin 5-rich
matrix deposited by 804G rat bladder carcinoma cells (C). The cells
were fixed, permeabilized, and stained with the antibody specific for
the IL-2 receptor. The localization of the chimeric receptors on the
basal cell surface was confirmed by confocal microscopy. The insets
show the vertical sections of the three-dimensional image sectioned
in the x-z and y-z planes. The perpendicular lines indicate the
positions from which the vertical sections were taken. 
2722
second FN type III repeat and the CS are also not sufficient to
direct the reporter domain to fibrillar structures since the
chimeric receptor b 4-1218-1456, containing only this portion
of the b 4 tail, also stained diffusely on the cell surface (Fig.
5F). Therefore, the results indicate that the region of the b 4
intracellular domain required for its fibrillar localization in
endothelial cells is contained within the first pair of Fn type III
repeats and the CS. This is the same region of the b 4
intracellular domain determined to be required for the
localization of a 6b 4 to type I hemidesmosomes in 804G rat
bladder carcinoma cells and type II hemidesmosome-like
structures in fibroblastic cells (Spinardi et al., 1993; Niessen et
al., 1997a). This result suggests that similar intracellular
protein interactions with the b 4 cytoplasmic tail may be
involved in regulating receptor localization to all three
structures. 
Receptor localization to type II hemidesmosome-like
structures in fibroblasts is also regulated by an
intracellular mechanism
In some epithelial cells that do not form type I
hemidesmosomes in culture, the a 6b 4 integrin has been found
to localize in structures that have been referred to as type II
hemidesmosomes. These structures have been described as
a 6b 4 concentrated in linear streaks flanking focal adhesions
containing vinculin (Uematsu et al., 1994). When recombinant
a 6b 4 is expressed in fibroblasts, it also concentrates at sites
resembling type II hemidesmosomes (Sanchez-Aparicio et al.,
1997; Niessen et al., 1997a). For these reasons, it is possible
that the localization of a 6b 4 in fibroblasts might also be
regulated by an intracellular mechanism. To test this
possibility, we expressed the IL-2R- b 4 chimera in a 6b 4-
deficient normal human fibroblasts. We found that the b 4
chimera consistently localized to type II hemidesmosome-like
structures in the absence of a 6b 4 expression (Fig. 6A-C). This
staining pattern is specific for the b 4 intracellular domain and
it is not a phenomenon of antibody exclusion, because the b 1
chimera directly colocalizes with vinculin in fibroblasts (Fig.
6D-F). This finding suggests that the b 4 intracellular domain
can also interact with intracellular proteins concentrated at
these sites flanking focal adhesions, independent of the
expression of recombinant a 6b 4.
The b 4 intracellular domain directs the localization
of HD1/plectin to fibrillar structures in endothelial
cells
We evaluated HD1/plectin as a candidate intracellular protein
required for the localization of the b 4 chimera to these fibrillar
structures, because the intermediate filament-associated
protein, HD1/plectin, is expressed in endothelial cells (Hieda
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Table 1. Fibrillar localization of the b 4 chimera and the recruitment of HD1/plectin
Transfected chimera
b 4 b 4 b 4 b 3 Control
b 4 chimera D 1315-1456 D 1315-1752 D 1488-1752 chimera chimera
Fibrillar localization* 57.5±2.4 7.2±3.6 0.7±0.5 54.8±4.3 54.2±6.0‡ 0
HD1 colocalization§ 86.4±0.6 0 0 84.2±1.4 0 0
*The percentage of transfected cells in which the various chimeric receptors were detected in a fibrillar localization pattern, or ‡were detected in focal
adhesions.
§The percentage of transfected cells with chimeric receptors in a fibrillar staining pattern in which HD1/plectin was colocalized with the chimera. It should be
noted that in cells expressing mutants which stain diffusely, HD1/plectin could not be detected in any distinct structure. In each case, the mean ± s.d. is given for
three independent experiments.
Fig. 5. The first pair of fibronectin type III repeats and the CS are required for receptor localization to fibrillar structures. HMEC-1 cells
transiently expressing the wild-type IL-2R-b 4 chimera (A), or chimeric receptor mutants b 4-D 1488-1752 (B), b 4- D 1315-1752 (C), b 4-D 1315-
1456 (D), b 4-1315-1456 (E) and b 4-1218-1456 (F) were seeded onto glass coverslips and stained with the IL-2 receptor specific antibody. The
samples were analyzed on an Olympus Model BX60 microscope equipped with epifluorescence. Bar, 10 m m.
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et al., 1992) and is found colocalized with a 6b 4 in both type I
and type II hemidesmosomes (Uematsu et al., 1994). When we
examined the staining pattern of HD1/plectin in untransfected
HMEC-1 cells, HD1/plectin consistently displayed a diffuse
staining pattern and could not be detected in any distinct
structures (data not shown). However, in cells transiently
expressing the b 4 chimera, HD1/plectin consistently
colocalized with the wild-type b 4 chimera at fibrillar structures,
as shown in Fig. 7A-C and Table 1. The recruitment of
HD1/plectin is specific for the b 4 intracellular domain because
HD1/plectin was diffusely distributed in cells expressing the
b 1 chimera, which is localized specifically in focal adhesions
(Fig. 7D,E). When we examined the localization of
HD1/plectin in endothelial cells expressing chimeric receptors
with various deletions in the b 4 intracellular domain, we found
that the chimeras that targeted to fibrillar structures were also
able to consistently direct the localization of HD1/plectin (Fig.
7 and Table 1). HD1/plectin had no distinct localization pattern
in cells expressing b 4 mutants, which remained diffuse on the
cell surface (Fig. 7F,G). Thus, these data demonstrate that the
b 4 intracellular domain, in the absence of the a 6 subunit and
any extracellular interaction with the subendothelial matrix, is
sufficient to direct the localization of HD1/plectin in
endothelial cells. In addition, because HD1/plectin is known to
bind to vimentin (Nikolic et al., 1996), the ability of the b 4
intracellular domain to direct the localization of HD1/plectin
Fig. 6. Localization to type II hemidesmosomes-like structures in fibroblasts is regulated by an intracellular mechanism. Normal human
fibroblasts transiently expressing the wild-type b 4 chimera (A-C) or the b 1 chimera (D-F) were seeded in serum-containing medium and then 15
hours later were fixed and double-stained with antibodies to the IL-2 receptor (A and D) and to vinculin (B and E). Samples were analyzed on
an Olympus Model BX60 microscope equipped with epifluorescence. Overlayed images (C and F) were computer generated. Bars, 10 m m.
Fig. 7. The b 4 intracellular
domain directs the
localization of HD1/plectin to
fibrillar structures in
microvascular endothelial
cells. HMEC-1 cells
transiently expressing the
wild-type b 4 chimera (A-C),
the wild-type b 1 chimera
(D,E) and b 4 chimera mutant
b 4-D 1315-1752 (F,G) were
seeded as previously
described in Fig. 1. Samples
were dual-labeled with
antibodies specific for the IL-
2 receptor (A,D,F) and mAb-
121 specific for HD1/plectin
(B,E,G). The area of the cell
showing the colocalization of
HD1/plectin and the b 4
chimera is encircled. Samples
were analyzed on an Olympus
Model BX60 microscope
equipped with epifluorescence
and the overlayed image in C
was computer generated.
Bars,10 m m.
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provides a potential mechanism by which a 6b 4 may be linked
to the vimentin intermediate filament system in endothelial
cells.
Recombinant a 6b 4-containing type I
hemidesmosome-like structures form when
transfected endothelial cells adhere to a laminin 5-
rich matrix
The identity of the laminin isoforms expressed in
subendothelial matrices in situ has not been fully characterized.
However, EE laminin, which is related to laminin 5, has been
observed in the basement membrane of microvascular
endothelial cells (Carter et al., 1994). Therefore, we were
interested in determining the response of endothelial cells
expressing recombinant a 6b 4 to a laminin 5-rich matrix to
determine whether recombinant a 6b 4 would assemble into an
adhesion structure distinct from the fibrillar structures detected
when cells were cultured on glass coverslips in the presence of
serum. When endothelial cells were transiently transfected
with recombinant a 6b 4 and plated on a laminin 5-rich matrix
for 15 hours, the a 6b 4 integrin concentrated in a ‘Swiss-
cheese’-like staining pattern, typical of type I
hemidesmosomes (Fig. 8A). This same localization pattern
was observed for recombinant a 6b 4 when expressed in early
passage primary dermal microvascular endothelial cells plated
on laminin 5 (data not shown). This result indicates that certain
a 6b 4 ligands can regulate the subcellular localization of a 6b 4
in endothelial cells. However, even though a 6b 4 redistributed
to what appears to be type I-like hemidesmosomes, the fibrillar
structure also persisted. When cells transfected with only the
IL-2R- b 4 chimera were plated on a laminin 5-rich matrix, the
b 4 chimera concentrated in these fibrillar structures (Fig. 8B).
In addition, in cells expressing both the recombinant a 6b 4
receptor and the IL-2R- b 4 chimera, the b 4 chimera was
observed both at fibrillar structures lacking a 6b 4 and at type I
hemidesmosome-like structures along with recombinant a 6b 4
(Fig. 8C,D). Therefore, the b 4 tail is also sufficient to direct a
reporter domain to type I hemidesmosome-like structures
formed by recombinant a 6b 4 expressed in endothelial cells.
This result suggests that cellular proteins, which can bind to
the b 4 tail, are recruited to these a 6b 4-mediated adhesions. The
localization of the b 4 chimera to type I-like hemidesmosomes
is dependent upon the expression of recombinant a 6b 4.
The a 6b 4 integrin associates with vimentin-type
intermediate filaments in endothelial cells
Since the b 4 tail is sufficient to recruit the intermediate
filament-associated protein HD1/plectin, we tested whether the
a 6b 4 integrin interacts with vimentin intermediate filaments in
endothelial cells. HMEC-1 cells transiently transfected with
recombinant a 6b 4, the wild-type IL2-R-b 4 chimera, or mock
transfected, were seeded on a laminin 5-rich matrix. After 14-
18 hours, the cells were extracted with a Tween-
40/deoxycholate extraction buffer that removes the cytosol and
the bulk of the actin cytoskeleton and associated proteins, but
not the intermediate filament cytoskeleton and its associated
proteins (Rabinovitz and Mercurio, 1997; Capco et al., 1982).
Subsequent to extraction, the cells were fixed and the presence
of vimentin, a 6b 4, b 1 integrins or the b 4 chimera were
determined by immunofluorescence microscopy. The fibrillar
structures, as well as the type I hemidesmosome-like
structures, were both resistant to extraction (Fig. 9A,C). In
contrast, b 1-containing focal contacts observed in unextracted
cells (Fig. 9E) were entirely lost upon extraction (Fig. 9F,G).
Thus, the data suggests that both the type I hemidesmosome-
like structures and the novel fibrillar structures are specifically
associated with the vimentin-type intermediate filament
cytoskeleton. Furthermore, the b 4 tail is sufficient to mediate
association with the vimentin cytoskeleton, since the IL2-R- b 4
chimera resisted extraction and colocalized with the vimentin
cytoskeleton in fibrillar structures in extracted cells. Taken
together, these results provide further evidence in support of
our hypothesis that the a 6b 4 integrin is assembled into distinct
intermediate filament-associated structures in endothelial cells.
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Fig. 8. Recombinant a 6 b 4-containing type I hemidesmosome-like
structures form when transfected endothelial cells adhere to a
laminin 5-rich matrix. HMEC-1 cells transiently expressing either
the recombinant a 6b 4 receptor (A), the wild-type IL-2R-b 4 chimera
(B) or both recombinant a 6b 4 and the wild-type b 4 chimera (C,D)
were seeded on a laminin 5-rich matrix deposited by 804G cells. The
cells were immunostained with mAb 3E1 specific for the
recombinant a 6 b 4 receptor (A,D) or with an antibody specific for the
IL-2 receptor (B,C). C and D show a single cell dual-labeled with the
two antibodies. Bars, 10 m m.
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The association of the a 6b 4 integrin with the vimentin
cytoskeleton was further confirmed by biochemical analysis.
HMEC-1 cells transiently transfected with recombinant a 6b 4
were seeded onto a laminin 5-rich matrix for 36 hours. Cells
were extracted with the Tween-40/deoxycholate extraction
buffer. The presence of vimentin, the b 4 subunit and vinculin
in the extraction buffer soluble and insoluble fractions were
analyzed by western blot. As shown in Fig. 10, a 6b 4 and
vimentin were enriched in the insoluble fraction. In contrast,
the actin-associated protein, vinculin, was present in the
soluble fraction, but was undetectable in the insoluble fraction,
further confirming that a 6b 4 specifically associates with the
vimentin-type intermediate filament cytoskeleton in
endothelial cells.
DISCUSSION
In this study, we expressed recombinant a 6b 4 in the
microvascular endothelial cell line HMEC-1 to determine
whether a 6b 4 can be assembled into adhesion structures by
Fig. 9. a 6 b 4-containing
structures are specifically
associated with the vimentin
cytoskeleton. HMEC-1 cells
transiently expressing the
recombinant a 6b 4 receptor
(A,B), the wild-type IL-2R-b 4
chimera (C,D) or mock-
transfected HMEC-1 cells (E-
G) were seeded on a laminin 5-
rich matrix for 14-18 hours in
serum-containing medium. The
cells were extracted with a
Tween-40/deoxycholate buffer
for 3 minutes prior to fixation
and were double-stained with
either the rat mAb GoH3,
specific for the a 6 integrin
subunit (A), the FITC-
conjugated mAb specific for the
IL-2 receptor (C), or the FITC-
conjugated mAb K20 specific
for the b 1 integrin subunit (F),
in combination with the mouse
mAb VIM 3B4 specific for
vimentin (B,D,G) as described
in Materials and Methods. In E,
cells were fixed, permeabilized
with 0.4% Triton X-100, and
then stained with mAb K20 as a
control. Bars, 10 m m.
Fig. 10. a 6 b 4 is enriched in the cell fraction specifically containing
intermediate filaments and associated proteins. HMEC-1 cells were
transiently transfected with the a 6A and b 4A integrin subunits and
plated onto a laminin 5-rich matrix. Cellular components were
fractionated into soluble and insoluble pools based on their
solubility in a ‘cytoskeletal’ buffer, which specifically solubilizes
cellular contents that are associated with microfilaments but not
associated with the intermediate filament cytoskeleton, as described
in Materials and Methods. 10 m g of protein from a whole cell lysate
(lane 1) and the soluble (lane 2) and insoluble (lane 3) fractions
were analyzed by western blot with an anti- b 4 integrin polyclonal
antibody (A), reprobed with the anti-vimentin antibody clone VIM
13.2 (C), and then with the anti-vinculin antibody clone VIN-11-5
(B).
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endothelial cells. In the absence of exogenous laminin, we find
that a 6b 4 concentrates in fibrillar structures on the basal cell
surface. Biochemical analysis indicates that this structure is
specifically associated with the vimentin intermediate filament
cytoskeleton. A chimeric receptor containing the b 4
cytoplasmic domain connected to an extracellular reporter
becomes concentrated in this structure, and is independent of
the expression of recombinant a 6b 4. This suggests that this
fibrillar structure can form in the absence of a 6b 4 and that the
recruitment of receptors to this structure occurs by an
intracellular mechanism involving the b 4 tail. We demonstrate
that the region of the b 4 cytoplasmic tail required for its
localization to these fibrillar structures in endothelial cells is
the same region previously described to be required for a 6b 4
localization to both type I hemidesmosomes in epithelial cells
and type II-like hemidesmosomes in fibroblastic cells (Spinardi
et al., 1993; Niessen et al., 1997a). This suggests that similar
protein interactions involving the b 4 tail are involved in
regulating a 6b 4 localization at all three structures. We have also
shown that the b 4 cytoplasmic tail is sufficient to recruit
HD1/plectin to these fibrillar structures, as well as to mediate
association with the vimentin cytoskeleton. Lastly, we have
demonstrated that in the presence of laminin 5, a 6b 4 assembles
into a type I hemidesmosome-like structure that is also
associated with vimentin intermediate filaments. Thus, the
presence of specific a 6b 4 ligands and the b 4 tail can regulate
the assembly of distinct vimentin-associated structures in
endothelial cells. 
Interestingly, the fibrillar structures on the basal surface of
endothelial cells appear to be formed independently of a 6b 4,
because the IL-2R-b 4 chimera concentrates at these fibrillar
structures on the basal surface of the cell in the absence of
expression of recombinant a 6b 4. Consistent with this data, we
have not been able to detect a 6b 4 ligands containing laminin
chains b 1, a 3, a 2 and b 2 in these structures by
immunofluorescence microscopy. It is possible that this
structure is formed by integrin-matrix interactions other than
those mediated by a 6b 4. However, we have also been unable
to localize other integrins at this structure, including integrins
containing a 2, a 3, a 5, a v, b 1 and b 3 subunits (data not shown),
suggesting that non-integrin adhesion receptors may be
localized at these structures. Although the mechanism
regulating the formation of this fibrillar structure is not yet
known, the b 4 chimera is detected in these structures within 6
hours of plating. This is the earliest time post-transfection that
the expression of the chimera can be detected at the cell surface
(data not shown).
Interestingly, the region of the b 4 cytoplasmic tail involved
in regulating this fibrillar localization in endothelial cells has
previously been shown to direct receptor localization to type I
hemidesmosomes in epithelial cells and type II-like
hemidesmosomes in fibroblasts (Spinardi et al., 1993; Niessen
et al., 1997a), suggesting that the same cellular protein(s) is
responsible for directing the localization of b 4 to the basal cell
surface in epithelial, endothelial and fibroblastic cell types.
Although the intracellular protein interactions directing the
localization of a 6b 4 appear to be the same in all three cell types
examined, these interactions occur in distinct structures in each
cell type. In epithelial cells, they occur at type I
hemidesmosomes (Spinardi et al., 1993); in endothelial cells,
interactions occur at a fibrillar structure on the basal cell
surface (see Figs 1 and 4) and in fibroblasts, they occur at type
II-like hemidesmosomal structures (Niessen et al., 1997a).
Interestingly, the same region of the b 4 intracellular domain
required for its localization to fibrillar structures is also the
region required for its ability to recruit HD1/plectin to these
sites. Thus, the b 4 intracellular domain interacts with specific
proteins in endothelial cells that can direct its localization to
fibrillar structures, and the same region of the b 4 intracellular
domain is also sufficient to direct the localization of the
intermediate filament-associated protein HD1/plectin to these
structures. Our results suggest that the cellular protein involved
in directing the localization of a 6b 4 and the IL-2R- b 4 chimera
to these structures is not HD1/plectin, because HD1/plectin
cannot be detected in any distinct staining pattern until the
wild-type b 4 chimera or chimeric mutant b 4-D 1488-1752 is
expressed. This finding is in agreement with others whose data
indicate that the cytoplasmic domain of b 4 can directly interact
with plectin and can determine the subcellular distribution of
HD1/plectin (Sanchez-Aparicio et al., 1997; Rezniczek et al.,
1998; Niessen et al., 1997b). However, we and others have not
been able to identify a separate region of the b 4 intracellular
domain involved in regulating receptor localization to the basal
cell surface from a region involved in targeting HD1/plectin to
these structures. Both events appear to require amino acids
contained within the first pair of FN type III repeats and the
CS.
Although a 6b 4 concentrates in fibrillar structures in the
absence of exogenous ligand, the availability of specific a 6b 4
ligands can regulate the distribution of a 6b 4 in endothelial
cells. When endothelial cells expressing recombinant a 6b 4
were plated on a laminin 5-rich matrix, the a 6b 4 integrin
redistributed from the fibrillar structures to type I
hemidesmosome-like structures. The fibrillar structure,
however, persisted because in the absence of recombinant
a 6b 4, the IL-2R- b 4 chimera remained fibrillar on cells plated
on a laminin 5 matrix. However, when cells expressing both
the recombinant a 6b 4 receptor and the IL-2R- b 4 chimera were
plated on a laminin 5 matrix, the chimera partially redistributed
to these a 6b 4-containing structures, suggesting that additional
cytoplasmic proteins may also redistribute to this structure and
may allow for the recruitment of the b 4 chimera. 
Although there is ultrastructural evidence suggesting the
association of the cytokeratin-type intermediate filament
cytoskeleton with both type I and type II hemidesmosomes
(Stepp et al., 1990; Uematsu et al., 1994), there is no
biochemical evidence to confirm a linkage between a 6b 4 and
the vimentin type intermediate filament cytoskeleton in any
cellular structure. In this study, an in situ extraction technique
was used to specifically solubilize all cellular components
except for the intermediate filament cytoskeleton and its
associated proteins. Using immunofluorescence microscopy,
we show that both the fibrillar structure as well as the type I
hemidesmosome-like structures remain organized in extracted
cells, confirming that both a 6b 4-containing structures detected
in endothelial cells are associated with vimentin intermediate
filaments. Importantly, the b 4 tail was shown to be sufficient
to mediate association with the vimentin cytoskeleton. The
association of the a 6b 4 integrin with vimentin was further
confirmed by western blot analysis, which illustrated a specific
enrichment of the b 4 subunit and vimentin in the Tween-
40/deoxycholate buffer-insoluble fraction. Actin-associated
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proteins were present in the soluble fraction, yet were
undetectable in the insoluble fraction. In conclusion, our data
demonstrate that endothelial cells contain the components
necessary to organize a 6b 4 into distinct vimentin-associated
structures on their basal cell surface and that the subcellular
localization of a 6b 4 and, ultimately, its contribution to
endothelial function will depend upon the availability of
specific a 6b 4 ligands.
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Note added in proof
A recent study has separated the localization of a 6b 4 in type 1
hemidesmosomes from the recruitment of HD1/pectin.
Schaapveld et al. (1998) J. Cell Biol. 142, 271-284.
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